# US 2019/0314158 A1 · Subchondral treatment to prevent the progression of osteoarthritis of the joint

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0314158 A1
- Document ID: US20190314158A1
- Status: Published application
- Kind: A1
- Application number: 16/453,388
- Filed: 2019-06-26
- Published: 2019-10-17
- Earliest claimed: 2011-08-07
- Assignees: Zimmer Knee Creations, Inc.
- Applicants: Zimmer Knee Creations, Inc.
- Inventors: Peter F. Sharkey; Charles F. Leinberry
- Web page: https://patentgrep.com/patent/US20190314158A1

## CPC

- A61F 2/30756: {Cartilage endoprostheses (A61F2/3603 takes precedence)}
- A61B 1/317: for bones or joints, e.g. osteoscopes or arthroscopes
- A61B 5/0036: {including treatment, e.g., using an implantable medical device, ablating, ventilating}
- A61B 5/055: involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
- A61B 5/4504: {Bones (A61B5/4547 takes precedence)}
- A61B 5/4514: {Cartilage}
- A61B 5/4528: {Joints (A61B5/4533, A61B5/4538 take precedence)}
- A61B 5/4878: {Evaluating oedema}
- A61B 6/032: {Transmission computed tomography [CT]}
- A61B 6/505: {for diagnosis of bone}
- A61B 8/0875: {for diagnosis of bone}
- A61B 17/1764: {for the knee}
- A61F 2/28: Bones
- A61F 2/30: Joints
- A61F 2/38: for elbows or knees
- A61F 2/389: {Tibial components (A61F2/3868 takes precedence)}
- A61F 2/4601: {for introducing bone substitute, for implanting bone graft implants or for compacting them in the bone cavity}
- A61F 2/4603: {for insertion or extraction of endoprosthetic joints or of accessories thereof}
- A61F 2/4657: {Measuring instruments used for implanting artificial joints (for surgical instruments A61B90/06)}
- A61B 17/3423: {Access ports, e.g. toroid shape introducers for instruments or hands (access sites for liquids A61M39/0247)}
- A61B 17/3472: {for bones, e.g. intraosseus injections}
- A61F 2002/2817: {Bone stimulation by chemical reactions or by osteogenic or biological products for enhancing ossification, e.g. by bone morphogenetic or morphogenic proteins [BMP] or by transforming growth factors [TGF]}
- A61F 2002/2821: {Bone stimulation by electromagnetic fields or electric current for enhancing ossification}
- A61F 2002/2835: {Bone graft implants for filling a bony defect or an endoprosthesis cavity, e.g. by synthetic material or biological material}
- A61F 2002/2839: {Bone plugs or bone graft dowels}
- A61F 2002/2892: {Tibia}
- A61F 2002/30011: {differing in porosity}
- A61F 2002/30014: {differing in elasticity, stiffness or compressibility}
- A61F 2002/4635: {using minimally invasive surgery}
- A61F 2002/4662: {for measuring penetration depth}
- A61F 2310/00293: containing a phosphorus-containing compound, e.g. apatite
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

Methods for the prevention, or delayed onset or progression of, bone marrow edema or bone marrow lesion, and subchondral treatment to prevent the progression of osteoarthritis of a joint are disclosed. The methods involve treating the subchondral bone, while preserving, as much as possible, the joint's articular and cartilage surface. The methods could be performed before, during, or after an initial arthroscopic surgery to repair the joint. Associated devices and instruments for treatment of the subchondral bone are also disclosed.

## Claims

### Claim at position 1

-14. (canceled)

### Claim 15

A method for treating subchondral bone in a first bone adjacent a joint in a patient to try to prevent or delay the onset of a bone marrow lesion or bone marrow edema in the subchondral bone, the first bone having articular cartilage, the subchondral bone occurring under the articular cartilage, the method comprising:
obtaining results of a chemical or biological assay that has been performed on the patient, the chemical or biological assay usable to determine if a bone marrow lesion or bone marrow edema exists in the subchondral bone, wherein the results obtained fail to detect a bone marrow lesion or bone marrow edema in the subchondral bone;
creating, despite the results of the chemical or biological assay failing to detect a bone marrow lesion or bone marrow edema in the subchondral bone, an access path to the subchondral bone, wherein said creating is conducted without creating a void in the subchondral bone that opens into the overlying articular surface of the first bone so as to preserve an existing condition of the overlying articular surface of the first bone; and
injecting an injectable fluid material into the subchondral bone via the access path for treating the subchondral bone, wherein the injectable fluid material includes an osteogenic, osteoconductive and/or osteoinductive material.

### Claim 16 (depends on 15)

The method of claim 15, wherein the injectable fluid material is left in the subchondral bone without also delivering and leaving a solid structural implant in the subchondral bone in addition to the injectable fluid material.

### Claim 17 (depends on 15)

The method of claim 15, wherein the joint is a knee joint.

### Claim 18 (depends on 17)

The method of claim 17, wherein the subchondral bone is in a proximal tibia.

### Claim 19 (depends on 17)

The method of claim 17, wherein the subchondral bone is in a distal femur.

### Claim 20 (depends on 15)

The method of claim 15, wherein the joint is a hip joint.

### Claim 21 (depends on 15)

The method of claim 15, wherein the joint is an ankle joint.

### Claim 22 (depends on 15)

The method of claim 15, wherein the joint is a shoulder joint.

### Claim 23 (depends on 15)

The method of claim 15, wherein the injectable fluid material includes bone marrow.

### Claim 24 (depends on 15)

The method of claim 15, wherein the injectable fluid material is effective to reinforce the subchondral bone.

### Claim 25 (depends on 15)

The method of claim 15, wherein the injectable fluid material includes a calcium phosphate.
